EVRS awards intraocular surgery simulator developers

Article

Markus Schill, PhD and Clemens Wagner, PhD of VRMagic GmbH have received the European VitreoRetinal Society's annual Relja Zivojnovic Award for outstanding contributions to the field of vitreoretinal surgery.

Markus Schill, PhD and Clemens Wagner, PhD of VRMagic GmbH have received the European VitreoRetinal Society's annual Relja Zivojnovic Award for outstanding contributions to the field of vitreoretinal surgery. The award was conferred in recognition of the virtual reality ocular surgery simulator, EYESi, that Dr Schill and Dr Wagner developed to enable surgeons to broaden their experience and practice and refine techniques for vitreoretinal surgery without endangering patient safety or comfort.

The EYESi machine - developed by a team of scientists led by Dr Schill and Dr Wagner at the University of Mannheim, Germany - was launched in 2001 to coincide with the establishment of VRMagic, the company formed by seven of the scientists involved in the creation of the EYESi. The training platform allows surgeons to practice techniques under uniform conditions, but can also be adjusted for individual needs. The machine, which can also be used for cataract surgery training, is now available around the world.

The award was presented during a ceremony held on September 8 during the EVRS annual meeting, held this year in Prague, the Czech Republic.

From left to right: Dr Klaus Lucke, Vice President EVRS, Dr Markus Schill and Dr Clemens Wagner, VRmagic, at the award ceremony in Prague on the 8th September 2008.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.